Apheris
Apheris is a federated data network and AI infrastructure company that enables pharmaceutical organizations to collaboratively build superior drug discovery AI models without sharing proprietary data. The platform delivers drug discovery AI models through secure, local applications featuring secure local inference where models run in the user's environment so data, queries, and outputs stay in-house; in-house…
Funding snapshot
About
Apheris is a federated data network and AI infrastructure company that enables pharmaceutical organizations to collaboratively build superior drug discovery AI models without sharing proprietary data. The platform delivers drug discovery AI models through secure, local applications featuring secure local inference where models run in the user's environment so data, queries, and outputs stay in-house; in-house benchmarking to compare model versions on curated internal datasets for understanding reliability; and customization capabilities to fine-tune models for specific targets and chemotypes with results integrated via GUI or API. Apheris powers the industry's largest federated data networks spanning multiple pharmaceutical organizations, including the Artificial Intelligence Structural Biology (AISB) Network, an unprecedented collaboration among AbbVie, Astex, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Johnson & Johnson, Sanofi, and Takeda aimed at transforming AI drug discovery through state-of-the-art models trained on unique data from multiple biopharma companies without exposing proprietary information. Additional networks include the ADMET Network for designing more informative batches and optimizing experimental capacity in DMTA cycles, and the Antibody Developability Network for advancing antibody R&D with purpose-built datasets and federated AI training. Apheris also offers ApherisFold, enabling teams to run co-folding models locally, benchmark on in-house data, and fine-tune on proprietary data, with federated networks extending fine-tuning across organizations. Companies can engage with Apheris by using applications locally, joining federated data networks, or building their own networks using Apheris' federated infrastructure. Founded in 2019 and headquartered in Berlin, Germany, Apheris has raised $20.8M in Series A funding from investors including LocalGlobe, Another, System One, Dig Ventures, Bmbf, Octopus Ventures, Heal Capital, OTB Ventures, eCAPITAL, and Intel Ignite.
Business model
AI Infrastructure > Enabling Technologies > Software > Training Data > Federated Learning,
Life Sciences Tech > Data Analysis Platforms
Founders & team highlights
Serial Founder
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
NovaHealth AI
NovaHealth AI automates visit summaries, coding suggestions, and prior-authorization drafts for mid-sized provider groups.
ScreenPoint
Developer of artificial intelligence software for analyzing breast imaging mammograms. This technology integrates with existing medical imaging hardware to assist radiologists in detecting cancer.
Bioz
Developer of AI search engine for scientific experimentation.
Rad AI
Developer of radiology artificial intelligence software for workflow and reporting. The software aims to improve efficiency and reduce fatigue for radiologists.